The Advances, Challenges and Prospects of Bionic Limbs

Overview

This paper synthesizes current progress in bionic limb development, spanning the technological trajectory from mechanical prostheses to neuro-integrated systems. The review focuses on contemporary advances in sensory feedback reconstruction, neural-muscular interfacing, high-density electromyography signal decoding, and artificial intelligence-supported multi-degree-of-freedom control. The paper situates these technical developments within the broader context of clinical implementation barriers and anticipated future research directions.

Methods and approach

The review employs a structured examination of the bionic limb field organized around key technical domains and implementation phases. Advances are evaluated across neural signal acquisition and interpretation, interface design and stability, sensory restoration mechanisms, and control algorithms. Challenges are categorized by their nature—biological, biocompatible, economic, and accessibility-related—to delineate distinct obstacles to clinical translation. Prospective developments are assessed regarding their potential to enhance system naturalness, individualization, and functional reliability.

Key Findings

The paper identifies significant progress in neural signal acquisition through high-density electromyography approaches and in intuitive control through neuromuscular interface integration. Sensory feedback reconstruction and artificial intelligence-enabled motion control represent focal areas of recent advancement. However, critical barriers persist: instability in biological signal acquisition over extended use, biocompatibility constraints limiting implanted neural interface longevity, and substantial cost barriers restricting user accessibility. The synthesis indicates that current systems remain constrained by the gap between laboratory performance and sustained clinical functionality.

Implications

The convergence of neural interface technology and intelligent control algorithms is positioned as central to advancing system performance beyond current clinical limitations. Enhanced signal stability and biocompatible interface materials are identified as prerequisites for translating laboratory-demonstrated capabilities into durable clinical systems. The paper suggests that progress in personalization and functional stability will require parallel advancement in both hardware robustness and algorithmic adaptation.